"We are committed to embedding our transformation agenda, delivering the highest standards of care and fulfilling our purpose of helping people live longer, healthier, happier lives."
- Iñaki Ereño, CEO of Bupa Group
Chris Carroll has been appointed as CEO for Bupa Global, India & UK, subject to regulatory approval. He will replace Carlos Jaureguizar as of the 1st January 2026.
Prior to this appointment, Chris served as CEO of Bupa UK, moving from managing director of its health insurance business in Australia. Richard Washington, who currently operates as medical & healthcare director for Bupa, will succeed him, subject to regulatory approval.
READ MORE: Bupa makes internal CEO appointment following Perry’s departure
“We are on an exciting journey of collaboration across health systems and improving our customers’ health outcomes. Through our expansion of digital healthcare services Bupa Blua, we want more customers to have the peace of mind that their entire health journey can be with Bupa, through sickness and wellness, and at every life stage,” he said.
Having held the role of CEO for Bupa Global, India & UK since 2021, Carlos moves to CEO for Bupa’s Europe & Latin America (ELA) market, subject to regulatory approval.
Iñaki Ereño, CEO of Bupa Group, added: “These appointments are a testament to the unmatched strength and talent in our leadership teams across Bupa to drive customer centricity and innovative healthcare.
“We are committed to embedding our transformation agenda, delivering the highest standards of care and fulfilling our purpose of helping people live longer, healthier, happier lives.”
